Cognitive function during nicotine withdrawal: Implications for nicotine dependence treatment
Tóm tắt
Từ khóa
Tài liệu tham khảo
Ago, 2011, Pharmacological aspects of the acetylcholinesterase inhibitor galantamine, J. Pharmacol. Sci., 116, 6, 10.1254/jphs.11R01CR
AhnAllen, 2008, Early nicotine withdrawal and transdermal nicotine effects on neurocognitive performance in schizophrenia, Schizophr. Res., 100, 261, 10.1016/j.schres.2007.07.030
Allison, 2013, Nicotine improves performance in an attentional set shifting task in rats, Neuropharmacology, 64, 314, 10.1016/j.neuropharm.2012.06.055
Alvarez, 2006, Executive function and the frontal lobes: a meta-analytic review, Neuropsychol. Rev., 16, 17, 10.1007/s11065-006-9002-x
Andreasen, 2009, Antidepressant-like effects of nicotinic acetylcholine receptor antagonists, but not agonists, in the mouse forced swim and mouse tail suspension tests, J. Psychopharmacol., 23, 797, 10.1177/0269881108091587
Ashare, 2012, Effects of smoking abstinence on impulsive behavior among smokers high and low in ADHD-like symptoms, Psychopharmacology (Berl), 219, 537, 10.1007/s00213-011-2324-2
Ashare, 2012, Effects of varenicline and bupropion on cognitive processes among nicotine-deprived smokers, Exp. Clin. Psychopharmacol., 20, 63, 10.1037/a0025594
Ashare, 2012, Cognitive effects of the acetylcholinesterase inhibitor, donepezil, in healthy, non-treatment seeking smokers: a pilot feasibility study, Drug Alcohol Depend., 126, 263, 10.1016/j.drugalcdep.2012.04.019
Atzori, 2008, Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal, J. Clin. Psychopharmacol., 28, 667, 10.1097/JCP.0b013e31818c9bb8
Baddeley, 2003, Working memory: looking back and looking forward, Nat. Rev. Neurosci., 4, 829, 10.1038/nrn1201
Baddeley, 2007
Ballard, 2001, Assessing attention: comparison of response-inhibition and traditional continuous performance tests, J. Clin. Exp. Neuropsychol., 23, 331, 10.1076/jcen.23.3.331.1188
Bancroft, 2000, Ventral hippocampal alpha4beta2 nicotinic receptors and chronic nicotine effects on memory, Neuropharmacology, 39, 2770, 10.1016/S0028-3908(00)00099-X
Barr, 2008, The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls, Neuropsychopharmacology, 33, 480, 10.1038/sj.npp.1301423
Beaver, 2011, The effects of nicotine replacement on cognitive brain activity during smoking withdrawal studied with simultaneous fMRI/EEG, Neuropsychopharmacology, 36, 1792, 10.1038/npp.2011.53
Bekker, 2005, Acute effects of nicotine on attention and response inhibition, Pharmacol. Biochem. Behav., 82, 539, 10.1016/j.pbb.2005.10.009
Benowitz, 2006, Female sex and oral contraceptive use accelerate nicotine metabolism, Clin. Pharmacol. Ther., 79, 480, 10.1016/j.clpt.2006.01.008
Bettany, 2001, Ventral hippocampal alpha 7 nicotinic receptor blockade and chronic nicotine effects on memory performance in the radial-arm maze, Pharmacol. Biochem. Behav., 70, 467, 10.1016/S0091-3057(01)00643-8
Beuten, 2006, Significant association of catechol-O-methyltransferase (COMT) haplotypes with nicotine dependence in male and female smokers of two ethnic populations, Neuropsychopharmacology, 31, 675, 10.1038/sj.npp.1300997
Biała, 2009, Influence of bupropion and calcium channel antagonists on the nicotine-induced memory-related response of mice in the elevated plus maze, Pharmacol. Rep. PR, 61, 236, 10.1016/S1734-1140(09)70027-1
Bickel, 2011, Remember the future: working memory training decreases delay discounting among stimulant addicts, Biol. Psychiatry, 69, 260, 10.1016/j.biopsych.2010.08.017
Biegon, 2010, Nicotine blocks brain estrogen synthase (aromatase): in vivo positron emission tomography studies in female baboons, Biol. Psychiatry, 67, 774, 10.1016/j.biopsych.2010.01.004
Birks, 2006, Cholinesterase inhibitors for Alzheimer's disease, Cochrane Database Syst. Rev., CD005593
Blondel, 2000, Characterisation of the effects of nicotine in the five-choice serial reaction time task in rats: antagonist studies, Psychopharmacology (Berl), 149, 293, 10.1007/s002130000378
Bora, 2012, Cognitive impairment in euthymic major depressive disorder: a meta-analysis, Psychol. Med., 1
Breese, 1997, Effect of smoking history on [3H]nicotine binding in human postmortem brain, J. Pharmacol. Exp. Ther., 282, 7
Bright, 2008, Abuse of medications employed for the treatment of ADHD: results from a large-scale community survey, Medscape J. Med., 10, 111
Broms, 2006, Genetic architecture of smoking behavior: a study of Finnish adult twins, Twin Res. Hum. Genet.: The Official Journal of the International Society for Twin Studies, 9, 64, 10.1375/twin.9.1.64
Cabeza, 2011, Overlapping parietal activity in memory and perception: evidence for the attention to memory model, J. Cogn. Neurosci., 23, 3209, 10.1162/jocn_a_00065
Cannady, 2009, Nicotinic antagonist effects in the mediodorsal thalamic nucleus: regional heterogeneity of nicotinic receptor involvement in cognitive function, Biochem. Pharmacol., 78, 788, 10.1016/j.bcp.2009.05.021
Chambers, 2009, Insights into the neural basis of response inhibition from cognitive and clinical neuroscience, Neurosci. Biobehav. Rev., 33, 631, 10.1016/j.neubiorev.2008.08.016
Chen, 2004, Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain, Am. J. Hum. Genet., 75, 807, 10.1086/425589
Chuah, 2008, Cholinergic augmentation modulates visual task performance in sleep-deprived young adults, J. Neurosci., 28, 11369, 10.1523/JNEUROSCI.4045-08.2008
Cole, 2010, Nicotine replacement in abstinent smokers improves cognitive withdrawal symptoms with modulation of resting brain network dynamics, Neuroimage, 52, 590, 10.1016/j.neuroimage.2010.04.251
Colilla, 2005, Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women, Pharmacogenet. Genomics, 15, 393, 10.1097/01213011-200506000-00004
Conn, 2008, Opportunities and challenges of psychiatric drug discovery: roles for scientists in academic, industry, and government settings, Neuropsychopharmacology, 33, 2048, 10.1038/sj.npp.1301638
Conners, 2000
Cornblatt, 1988, The continuous performance test, identical pairs version (CPT-IP): I. new findings about sustained attention in normal families, Psychiatry Res., 26, 223, 10.1016/0165-1781(88)90076-5
Cosgrove, 2009, beta2-Nicotinic acetylcholine receptor availability during acute and prolonged abstinence from tobacco smoking, Arch. Gen. Psychiatry, 66, 666, 10.1001/archgenpsychiatry.2009.41
Cosgrove, 2012, Sex differences in availability of beta2*-nicotinic acetylcholine receptors in recently abstinent tobacco smokers, Arch. Gen. Psychiatry, 69, 418, 10.1001/archgenpsychiatry.2011.1465
Coull, 1996, A fronto-parietal network for rapid visual information processing: a PET study of sustained attention and working memory, Neuropsychologia, 34, 1085, 10.1016/0028-3932(96)00029-2
Covey, 2008, Smoking cessation and inattention or hyperactivity/impulsivity: a post hoc analysis, Nicotine Tob. Res., 10, 1717, 10.1080/14622200802443536
Culhane, 2008, Predictors of early abstinence in smokers with schizophrenia, J. Clin. Psychiatry, 69, 1743, 10.4088/JCP.v69n1109
David, 2006, Reinforcing effects of nicotine microinjections into the ventral tegmental area of mice: dependence on cholinergic nicotinic and dopaminergic D1 receptors, Neuropharmacology, 50, 1030, 10.1016/j.neuropharm.2006.02.003
Davis, 2006, The effects of DHBE and MLA on nicotine-induced enhancement of contextual fear conditioning in C57BL/6 mice, Psychopharmacology (Berl), 184, 345, 10.1007/s00213-005-0047-y
Davis, 2007, Atomoxetine reverses nicotine withdrawal-associated deficits in contextual fear conditioning, Neuropsychopharmacology, 10.1038/sj.npp.1301315
Davis, 2008, Associative learning, the hippocampus, and nicotine addiction, Curr. Drug Abuse Rev., 1, 9, 10.2174/1874473710801010009
Davis, 2005, Withdrawal from chronic nicotine administration impairs contextual fear conditioning in C57BL/6 mice, J. Neurosci., 25, 8708, 10.1523/JNEUROSCI.2853-05.2005
Dawkins, 2007, A double-blind placebo-controlled experimental study of nicotine: II-Effects on response inhibition and executive functioning, Psychopharmacology (Berl), 190, 457, 10.1007/s00213-006-0634-6
Day, 2007, Differential effects of ciproxifan and nicotine on impulsivity and attention measures in the 5-choice serial reaction time test, Biochem. Pharmacol., 73, 1123, 10.1016/j.bcp.2006.12.004
De Biasi, 2011, Reward, addiction, withdrawal to nicotine, Annu. Rev. Neurosci., 34, 105, 10.1146/annurev-neuro-061010-113734
De la Garza, 2011, Evaluation of the effects of rivastigmine on cigarette smoking by methamphetamine-dependent volunteers, Prog. Neuropsychopharmacol. Bol. Psychiatry, 35, 1827, 10.1016/j.pnpbp.2011.07.006
de Wit, 2009, Impulsivity as a determinant and consequence of drug use: a review of underlying processes, Addict. Biol., 14, 22, 10.1111/j.1369-1600.2008.00129.x
Delrieu, 2011, Managing cognitive dysfunction through the continuum of Alzheimer's disease: role of pharmacotherapy, CNS Drugs, 25, 213, 10.2165/11539810-000000000-00000
Diehl, 2006, Galantamine reduces smoking in alcohol-dependent patients: a randomized, placebo-controlled trial, Int. J. Clin. Pharmacol. Ther., 44, 614, 10.5414/CPP44614
Diehl, 2009, Rivastigmine reduces tobacco craving in alcohol-dependent smokers, Pharmacopsychiatry, 42, 89, 10.1055/s-0028-1103295
Dluzen, 1997, Estrogen differentially modulates nicotine-evoked dopamine release from the striatum of male and female rats, Neurosci. Lett., 230, 140, 10.1016/S0304-3940(97)00487-4
Dolan, 2004, Neuropsychological deficits are associated with smoking cessation treatment failure in patients with schizophrenia, Schizophr. Res., 70, 263, 10.1016/j.schres.2004.01.006
Evans, 2009, Nicotine self-medication of cognitive-attentional processing, Addict. Biol., 14, 32, 10.1111/j.1369-1600.2008.00130.x
Evans, 2009, Neurocognitive variation in smoking behavior and withdrawal: genetic and affective moderators, Genes Brain Behav., 8, 86, 10.1111/j.1601-183X.2008.00445.x
Evins, 2005, Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia, J. Clin. Psychiatry, 66, 1184, 10.4088/JCP.v66n0915
Falcone, 2013, Age-related differences in working memory deficits during nicotine withdrawal, Addict. Biol., 10.1111/adb.12051
Farage, 2008, Cognitive, sensory, and emotional changes associated with the menstrual cycle: a review, Arch. Gynecol. Obstet., 278, 299, 10.1007/s00404-008-0708-2
Floresco, 2011, Pharmacological enhancement of memory and executive functioning in laboratory animals, Neuropsychopharmacology, 36, 227, 10.1038/npp.2010.158
Foldi, 2005, Detecting effects of donepezil on visual selective attention using signal detection parameters in Alzheimer's disease, Int. J. Geriatr. Psychiatry, 20, 485, 10.1002/gps.1319
Fox, 2005, The human brain is intrinsically organized into dynamic, anticorrelated functional networks, Proc. Natl. Acad. Sci. U. S. A., 102, 9673, 10.1073/pnas.0504136102
Fuemmeler, 2007, jsm051
Garvey, 1992, Predictors of smoking relapse among self-quitters: a report from the normative aging study, Addict. Behav., 17, 367, 10.1016/0306-4603(92)90042-T
George, 2007, Neurobiological links between nicotine addiction and schizophrenia, J. Dual Diagn., 3, 27, 10.1300/J374v03n03_04
George, 2002, Effects of smoking abstinence on visuospatial working memory function in schizophrenia, Neuropsychopharmacology, 26, 75, 10.1016/S0893-133X(01)00296-2
Gilbert, 2005, Dopamine receptor (DRD2) genotype-dependent effects of nicotine on attention and distraction during rapid visual information processing, Nicotine Tob. Res., 7, 361, 10.1080/14622200500125245
Gould, 2012, The duration of nicotine withdrawal-associated deficits in contextual fear conditioning parallels changes in hippocampal high affinity nicotinic acetylcholine receptor upregulation, Neuropharmacology, 62, 2118, 10.1016/j.neuropharm.2012.01.003
Green, 2005, Muscarinic and nicotinic receptor modulation of object and spatial n-back working memory in humans, Pharmacol. Biochem. Behav., 81, 575, 10.1016/j.pbb.2005.04.010
Greenstein, 2009, The effects of smoking and smoking abstinence on verbal and visuospatial working memory capacity, Exp. Clin. Psychopharmacol., 17, 78, 10.1037/a0015699
Gron, 2005, Cholinergic enhancement of episodic memory in healthy young adults, Psychopharmacology (Berl), 182, 170, 10.1007/s00213-005-0043-2
Gualtieri, 2007, Bupropion normalizes cognitive performance in patients with depression, MedGenMed: Medscape Gen. Med., 9, 22
Hahn, 2009, Performance effects of nicotine during selective attention, divided attention, and simple stimulus detection: an fMRI study, Cereb. Cortex, 19, 1990, 10.1093/cercor/bhn226
Hahn, 2007, Nicotine enhances visuospatial attention by deactivating areas of the resting brain default network, J. Neurosci., 27, 3477, 10.1523/JNEUROSCI.5129-06.2007
Hahn, 2011, Selective nicotinic receptor antagonists: effects on attention and nicotine-induced attentional enhancement, Psychopharmacology (Berl), 217, 75, 10.1007/s00213-011-2258-8
Hare, 2009, Self-control in decision-making involves modulation of the vmPFC valuation system, Science, 324, 646, 10.1126/science.1168450
Harrison, 2009, Nicotine deprivation and trait impulsivity affect smokers' performance on cognitive tasks of inhibition and attention, Exp. Clin. Psychopharmacol., 17, 91, 10.1037/a0015657
Heishman, 2010, Meta-analysis of the acute effects of nicotine and smoking on human performance, Psychopharmacology (Berl), 210, 453, 10.1007/s00213-010-1848-1
Hendricks, 2006, The early time course of smoking withdrawal effects, Psychopharmacology (Berl), 187, 385, 10.1007/s00213-006-0429-9
Herman, 2010, Cognitive effects of nicotine: genetic moderators, Addict. Biol., 15, 250, 10.1111/j.1369-1600.2010.00213.x
Hirvonen, 2004, C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo, Mol. Psychiatry, 9, 1060, 10.1038/sj.mp.4001561
Hodges, 1996, Maze procedures: the radial-arm and water maze compared, Brain Res. Cogn. Brain Res., 3, 167, 10.1016/0926-6410(96)00004-3
Hofmann, 2012, Executive functions and self-regulation, Trends Cogn. Sci., 16, 174, 10.1016/j.tics.2012.01.006
Hong, 2011, Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder, Arch. Gen. Psychiatry, 68, 1195, 10.1001/archgenpsychiatry.2011.83
Hopkins, 2012, Galantamine, an acetylcholinesterase inhibitor and positive allosteric modulator of nicotinic acetylcholine receptors, attenuates nicotine taking and seeking in rats, Neuropsychopharmacology, 37, 2310, 10.1038/npp.2012.83
Hughes, 1992, Tobacco withdrawal in self-quitters, J. Consult. Clin. Psychol., 60, 689, 10.1037/0022-006X.60.5.689
Hughes, 2007, Effects of abstinence from tobacco: valid symptoms and time course, Nicotine Tob. Res., 9, 315, 10.1080/14622200701188919
Humfleet, 2005, Preliminary evidence of the association between the history of childhood attention-deficit/hyperactivity disorder and smoking treatment failure, Nicotine Tob. Res., 7, 453, 10.1080/14622200500125310
Hutchinson, 2009, Posterior parietal cortex and episodic retrieval: convergent and divergent effects of attention and memory, Learn. Mem., 16, 343, 10.1101/lm.919109
Ikemoto, 2006, Primary reinforcing effects of nicotine are triggered from multiple regions both inside and outside the ventral tegmental area, J. Neurosci., 26, 723, 10.1523/JNEUROSCI.4542-05.2006
Jacobsen, 2005, Effects of smoking and smoking abstinence on cognition in adolescent tobacco smokers, Biol. Psychiatry, 57, 56, 10.1016/j.biopsych.2004.10.022
Jacobsen, 2007, Impact of smoking abstinence on working memory neurocircuitry in adolescent daily tobacco smokers, Psychopharmacology (Berl), 193, 557, 10.1007/s00213-007-0797-9
Jacobsen, 2006, C957T polymorphism of the dopamine D2 receptor gene modulates the effect of nicotine on working memory performance and cortical processing efficiency, Psychopharmacology (Berl), 188, 530, 10.1007/s00213-006-0469-1
Japuntich, 2007, Depression predicts smoking early but not late in a quit attempt, Nicotine Tob. Res., 9, 677, 10.1080/14622200701365301
Johnstone, 2007, Association of COMT Val108/158Met genotype with smoking cessation in a nicotine replacement therapy randomized trial, Cancer Epidemiol. Biomarkers Prev., 16, 1065, 10.1158/1055-9965.EPI-06-0936
Jonsson, 1999, Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers, Mol. Psychiatry, 4, 290, 10.1038/sj.mp.4000532
Kelly, 2008, Lack of beneficial galantamine effect for smoking behavior: a double-blind randomized trial in people with schizophrenia, Schizophr. Res., 103, 161, 10.1016/j.schres.2008.04.027
Kendziorra, 2011, Decreased cerebral alpha4beta2* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer's disease assessed with positron emission tomography, Eur. J. Nucl. Med. Mol. Imaging, 38, 515, 10.1007/s00259-010-1644-5
Kenney, 2011, The effects of acute, chronic, and withdrawal from chronic nicotine on novel and spatial object recognition in male C57BL/6J mice, Psychopharmacology (Berl), 217, 353, 10.1007/s00213-011-2283-7
Killen, 1997, Craving is associated with smoking relapse: findings from three prospective studies, Exp. Clin. Psychopharmacol., 5, 137, 10.1037/1064-1297.5.2.137
Kim, 1996, Nicotinic, muscarinic and dopaminergic actions in the ventral hippocampus and the nucleus accumbens: effects on spatial working memory in rats, Brain Res., 725, 231, 10.1016/0006-8993(96)00213-2
Kimmey, 2012, Donepezil, an acetylcholinesterase inhibitor, attenuates nicotine self-administration and reinstatement of nicotine seeking in rats, Addict. Biol.
Kirshenbaum, 2011, Nicotine-induced impulsive action: sensitization and attenuation by mecamylamine, Behav. Pharmacol., 22, 207, 10.1097/FBP.0b013e328345ca1c
Kollins, 2012, Effects of smoking abstinence on smoking-reinforced responding, withdrawal, and cognition in adults with and without attention deficit hyperactivity disorder, Psychopharmacology (Berl), 1
Kollins, 2009, Effects of smoking abstinence on reaction time variability in smokers with and without ADHD: an ex-Gaussian analysis, Drug Alcohol Depend., 100, 169, 10.1016/j.drugalcdep.2008.09.019
Kollins, 2005, Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults, Arch. Gen. Psychiatry, 62, 1142, 10.1001/archpsyc.62.10.1142
Kolokotroni, 2012, Effects of chronic nicotine, nicotine withdrawal and subsequent nicotine challenges on behavioural inhibition in rats, Psychopharmacology (Berl), 219, 453, 10.1007/s00213-011-2558-z
Koontz, 2005, Effects of galantamine on working memory and global functioning in patients with mild cognitive impairment: a double-blind placebo-controlled study, Am. J. Alzheimer's Dis. Other Demen., 20, 295, 10.1177/153331750502000502
Kouneiher, 2009, Motivation and cognitive control in the human prefrontal cortex, Nat. Neurosci., 12, 939, 10.1038/nn.2321
Kozink, 2010, Smoking withdrawal modulates right inferior frontal cortex but not presupplementary motor area activation during inhibitory control, Neuropsychopharmacology, 35, 2600, 10.1038/npp.2010.154
Kozink, 2010, Smoking withdrawal shifts the spatiotemporal dynamics of neurocognition, Addict. Biol., 15, 480, 10.1111/j.1369-1600.2010.00252.x
Krishnan-Sarin, 2007, Behavioral impulsivity predicts treatment outcome in a smoking cessation program for adolescent smokers, Drug Alcohol Depend., 88, 79, 10.1016/j.drugalcdep.2006.09.006
Kruk-Słomka, 2012, Involvement of cholinergic receptors in the different stages of memory measured in the modified elevated plus maze test in mice, Pharmacol. Rep. PR, 64, 1066, 10.1016/S1734-1140(12)70904-0
Kruk, 2011, Memory-related effects of cholinergic receptor ligands in mice as measured by the elevated plus maze test, Pharmacol. Rep., 63, 1372, 10.1016/S1734-1140(11)70701-0
Kumari, 2005, Nicotine use in schizophrenia: the self medication hypotheses, Neurosci. Biobehav. Rev., 29, 1021, 10.1016/j.neubiorev.2005.02.006
Kuryatov, 2008, Roles of accessory subunits in α4β2* nicotinic receptors, Mol. Pharmacol., 74, 132, 10.1124/mol.108.046789
Lachman, 1996, Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders, Pharmacogenetics, 6, 243, 10.1097/00008571-199606000-00007
Lawrence, 2003, Multiple neuronal networks mediate sustained attention, J. Cogn. Neurosci., 15, 1028, 10.1162/089892903770007416
Lawrence, 2002, Cognitive mechanisms of nicotine on visual attention, Neuron, 36, 539, 10.1016/S0896-6273(02)01004-8
Lerman, 2006, Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials, Neuropsychopharmacology, 31, 231, 10.1038/sj.npp.1300861
Lerman, 2007, Translational research in medication development for nicotine dependence, Nat. Rev. Drug Discov., 6, 746, 10.1038/nrd2361
Levin, 1994, Working memory performance and cholinergic effects in the ventral tegmental area and substantia nigra, Brain Res., 657, 165, 10.1016/0006-8993(94)90964-4
Levin, 1993, Chronic nicotinic stimulation and blockade effects on working memory, Behav. Pharmacol., 4, 179, 10.1097/00008877-199304000-00010
Levin, 1990, Chronic nicotine and withdrawal effects on radial-arm maze performance in rats, Behav. Neural Biol., 53, 269, 10.1016/0163-1047(90)90509-5
Levin, 2006, Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization, Psychopharmacology (Berl), 184, 523, 10.1007/s00213-005-0164-7
Levin, 2002, Nicotinic treatment for cognitive dysfunction, Curr. Drug Targets CNS Neurol. Disord., 1, 423, 10.2174/1568007023339102
Lezak, 2004
Liu, 2011, Varenicline prevents affective and cognitive exacerbation during smoking abstinence in male patients with schizophrenia, Psychiatry Res., 190, 79, 10.1016/j.psychres.2011.04.018
Livingstone, 2009, α7 and non-α7 nicotinic acetylcholine receptors modulate dopamine release in vitro and in vivo in the rat prefrontal cortex, Eur. J. Neurosci., 29, 539, 10.1111/j.1460-9568.2009.06613.x
Logan, 1994, On the ability to inhibit thought and action: a user's guide to the stop signal paradigm, 189
Logan, 1997, Impulsivity and inhibitory control, Psychol. Sci., 8, 60, 10.1111/j.1467-9280.1997.tb00545.x
Loughead, 2010, Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers, Biol. Psychiatry, 67, 715, 10.1016/j.biopsych.2010.01.016
Loughead, 2009, Effect of abstinence challenge on brain function and cognition in smokers differs by COMT genotype, Mol. Psychiatry, 14, 820, 10.1038/mp.2008.132
Markou, 2009, Removing obstacles in neuroscience drug discovery: the future path for animal models, Neuropsychopharmacology, 34, 74, 10.1038/npp.2008.173
McClernon, 2008, ADHD and smoking: from genes to brain to behavior, Ann. N. Y. Acad. Sci., 1141, 131, 10.1196/annals.1441.016
McClernon, 2008, Effects of smoking abstinence on adult smokers with and without attention deficit hyperactivity disorder: results of a preliminary study, Psychopharmacology (Berl), 197, 95, 10.1007/s00213-007-1009-3
McClernon, 2011, Smoking withdrawal symptoms are more severe among smokers with ADHD and independent of ADHD symptom change: results from a 12-day contingency-managed abstinence trial, Nicotine Tob. Res., 13, 784, 10.1093/ntr/ntr073
Mendrek, 2006, Working memory in cigarette smokers: comparison to non-smokers and effects of abstinence, Addict. Behav., 31, 833, 10.1016/j.addbeh.2005.06.009
Menon, 2010, Saliency, switching, attention and control: a network model of insula function, Brain Struct. Funct., 214, 655, 10.1007/s00429-010-0262-0
Merritt, 2012, Sex differences in the cognitive effects of tobacco abstinence: a pilot study, Exp. Clin. Psychopharmacol., 20, 258, 10.1037/a0027414
Mitsis, 2009, Age-related decline in nicotinic receptor availability with [(123)I]5-IA-85380 SPECT, Neurobiol. Aging, 30, 1490, 10.1016/j.neurobiolaging.2007.12.008
Moss, 2009, Prefrontal cognitive dysfunction is associated with tobacco dependence treatment failure in smokers with schizophrenia, Drug Alcohol Depend., 104, 94, 10.1016/j.drugalcdep.2009.04.005
Munafo, 2008, Association of COMT Val108/158Met genotype with smoking cessation, Pharmacogenet. Genomics, 18, 121, 10.1097/FPC.0b013e3282f44daa
Murrough, 2011, Cognitive dysfunction in depression: neurocircuitry and new therapeutic strategies, Neurobiol. Learn. Mem., 96, 553, 10.1016/j.nlm.2011.06.006
Myers, 2008, Dose-related enhancement of mood and cognition in smokers administered nicotine nasal spray, Neuropsychopharmacology, 33, 588, 10.1038/sj.npp.1301425
Newhouse, 2012, Nicotine treatment of mild cognitive impairment: a 6-month double-blind pilot clinical trial, Neurology, 78, 91, 10.1212/WNL.0b013e31823efcbb
Newhouse, 2011, Functional brain imaging of nicotinic effects on higher cognitive processes, Biochem. Pharmacol., 82, 943, 10.1016/j.bcp.2011.06.008
Nuechterlein, 2008, The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity, Am. J. Psychiatry, 165, 203, 10.1176/appi.ajp.2007.07010042
Ortega, 2013, Effects of chronic low- and high-dose nicotine on cognitive flexibility in C57BL/6J mice, Behav. Brain Res., 238, 134, 10.1016/j.bbr.2012.10.032
Owen, 2005, N-back working memory paradigm: a meta-analysis of normative functional neuroimaging studies, Hum. Brain Mapp., 25, 46, 10.1002/hbm.20131
Pandya, 2011, Allosteric modulators of the [alpha] 4 [beta] 2 subtype of neuronal nicotinic acetylcholine receptors, Biochem. Pharmacol., 82, 952, 10.1016/j.bcp.2011.04.020
Paolini, 2011, Mechanistic insights into nicotine withdrawal, Biochem. Pharmacol., 82, 996, 10.1016/j.bcp.2011.07.075
Patterson, 2010, Working memory deficits predict short-term smoking resumption following brief abstinence, Drug Alcohol Depend., 106, 61, 10.1016/j.drugalcdep.2009.07.020
Patterson, 2009, Varenicline improves mood and cognition during smoking abstinence, Biol. Psychiatry, 65, 144, 10.1016/j.biopsych.2008.08.028
Pergadia, 2006, Genetic analyses of DSM-IV nicotine withdrawal in adult twins, Psychol. Med., 36, 963, 10.1017/S0033291706007495
Perkins, 2010, Cross-validation of a new procedure for early screening of smoking cessation medications in humans, Clin. Pharmacol. Ther., 88, 109, 10.1038/clpt.2010.65
Perkins, 2008, Development of procedures for early screening of smoking cessation medications in humans, Clin. Pharmacol. Ther., 84, 216, 10.1038/clpt.2008.30
Perry, 2008, The role of impulsive behavior in drug abuse, Psychopharmacology (Berl), 200, 1, 10.1007/s00213-008-1173-0
Picciotto, 2008, It is not “either/or”: activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood, Prog. Neurobiol., 84, 329, 10.1016/j.pneurobio.2007.12.005
Poltavski, 2012, Lower but not higher doses of transdermal nicotine facilitate cognitive performance in smokers on gender non-preferred tasks, Pharmacol. Biochem. Behav., 102, 423, 10.1016/j.pbb.2012.06.003
Pomerleau, 2003, Smoking patterns and abstinence effects in smokers with no ADHD, childhood ADHD, and adult ADHD symptomatology, Addict. Behav., 28, 1149, 10.1016/S0306-4603(02)00223-X
Poorthuis, 2009, Nicotinic actions on neuronal networks for cognition: general principles and long-term consequences, Biochem. Pharmacol., 78, 668, 10.1016/j.bcp.2009.04.031
Portugal, 2007, Bupropion dose-dependently reverses nicotine withdrawal deficits in contextual fear conditioning, Pharmacol. Biochem. Behav., 88, 179, 10.1016/j.pbb.2007.08.004
Portugal, 2012, Strain-dependent effects of acute, chronic, and withdrawal from chronic nicotine on fear conditioning, Behav. Genet., 42, 133, 10.1007/s10519-011-9489-7
Portugal, 2012, Developmental effects of acute, chronic, and withdrawal from chronic nicotine on fear conditioning, Neurobiol. Learn. Mem., 97, 482, 10.1016/j.nlm.2012.04.003
Potter, 2008, Acute nicotine improves cognitive deficits in young adults with attention-deficit/hyperactivity disorder, Pharmacol. Biochem. Behav., 88, 407, 10.1016/j.pbb.2007.09.014
Powell, 2010, Relapse to smoking during unaided cessation: clinical, cognitive and motivational predictors, Psychopharmacology (Berl), 212, 537, 10.1007/s00213-010-1975-8
Powell, 2004, Cognitive and psychological correlates of smoking abstinence, and predictors of successful cessation, Addict. Behav., 29, 1407, 10.1016/j.addbeh.2004.06.006
Rabenstein, 2005, Impaired synaptic plasticity and learning in mice lacking beta-adducin, an actin-regulating protein, J. Neurosci., 25, 2138, 10.1523/JNEUROSCI.3530-04.2005
Raichle, 2001, A default mode of brain function, Proc. Natl. Acad. Sci. U. S. A., 98, 676, 10.1073/pnas.98.2.676
Ramos, 2007, Adrenergic pharmacology and cognition: focus on the prefrontal cortex, Pharmacol. Ther., 113, 523, 10.1016/j.pharmthera.2006.11.006
Ray, 2009, Effects of atomoxetine on subjective and neurocognitive symptoms of nicotine abstinence, J. Psychopharmacol. (Oxf), 23, 168, 10.1177/0269881108089580
Ray, 2009, Nicotine dependence: biology, behavior, and treatment, Annu. Rev. Med., 60, 247, 10.1146/annurev.med.60.041707.160511
Raybuck, 2009, Nicotine withdrawal-induced deficits in trace fear conditioning in C57BL/6 mice – a role for high-affinity beta2 subunit-containing nicotinic acetylcholine receptors, Eur. J. Neurosci., 29, 377, 10.1111/j.1460-9568.2008.06580.x
Raybuck, 2008, Varenicline ameliorates nicotine withdrawal-induced learning deficits in C57BL/6 mice, Behav. Neurosci., 122, 1166, 10.1037/a0012601
Robbins, 2002, The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry, Psychopharmacology (Berl), 163, 362, 10.1007/s00213-002-1154-7
Rollema, 2009, Preclinical pharmacology of the α4β2 nAChR partial agonist varenicline related to effects on reward, mood and cognition, Biochem. Pharmacol., 78, 813, 10.1016/j.bcp.2009.05.033
Rukstalis, 2005, Increases in hyperactive–impulsive symptoms predict relapse among smokers in nicotine replacement therapy, J. Subst. Abuse Treat., 28, 297, 10.1016/j.jsat.2005.02.002
Rush, 2005, Methylphenidate increases cigarette smoking, Psychopharmacology (Berl), 181, 781, 10.1007/s00213-005-0021-8
Sabri, 2008, Acetylcholine receptors in dementia and mild cognitive impairment, Eur. J. Nucl. Med. Mol. Imaging, 35, S30, 10.1007/s00259-007-0701-1
Sacco, 2005, Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms, Arch. Gen. Psychiatry, 62, 649, 10.1001/archpsyc.62.6.649
Sarter, 2001, The cognitive neuroscience of sustained attention: where top-down meets bottom-up, Brain Res. Rev., 35, 146, 10.1016/S0165-0173(01)00044-3
Sarter, 2011, Deficits in attentional control: cholinergic mechanisms and circuitry-based treatment approaches, Behav. Neurosci., 125, 825, 10.1037/a0026227
Sarter, 2009, nAChR agonist-induced cognition enhancement: integration of cognitive and neuronal mechanisms, Biochem. Pharmacol., 78, 658, 10.1016/j.bcp.2009.04.019
Semenova, 2007, Chronic nicotine administration improves attention while nicotine withdrawal induces performance deficits in the 5-choice serial reaction time task in rats, Pharmacol. Biochem. Behav., 87, 360, 10.1016/j.pbb.2007.05.009
Shoaib, 2005, Deficits in a sustained attention task following nicotine withdrawal in rats, Psychopharmacology (Berl), 178, 211, 10.1007/s00213-004-2004-6
Sofuoglu, 2010, Cognitive enhancement as a pharmacotherapy target for stimulant addiction, Addiction, 105, 38, 10.1111/j.1360-0443.2009.02791.x
Sofuoglu, 2011, Effects of galantamine on cocaine use in chronic cocaine users, Am. J. Addict., 20, 302, 10.1111/j.1521-0391.2011.00130.x
Sofuoglu, 2012, Galantamine attenuates some of the subjective effects of intravenous nicotine and improves performance on a Go No-Go task in abstinent cigarette smokers: a preliminary report, Psychopharmacology (Berl), 1
Sofuoglu, 2009, Cholinergic functioning in stimulant addiction: implications for medications development, CNS Drugs, 23, 939, 10.2165/11310920-000000000-00000
Sofuoglu, 2011, Galantamine improves sustained attention in chronic cocaine users, Exp. Clin. Psychopharmacol., 19, 11, 10.1037/a0022213
Sonne, 2010, The relationship between depression and smoking cessation outcomes in treatment-seeking substance abusers, Am. J. Addict., 19, 111, 10.1111/j.1521-0391.2009.00015.x
Sridharan, 2008, A critical role for the right fronto-insular cortex in switching between central-executive and default-mode networks, Proc. Natl. Acad. Sci. U. S. A., 105, 12569, 10.1073/pnas.0800005105
Staley, 2006, Human tobacco smokers in early abstinence have higher levels of β2* nicotinic acetylcholine receptors than nonsmokers, J. Neurosci., 26, 8707, 10.1523/JNEUROSCI.0546-06.2006
Stapleton, 2011, Association between DRD2/ANKK1 Taq1A genotypes, depression and smoking cessation with nicotine replacement therapy, Pharmacogenet. Genomics, 21, 447, 10.1097/FPC.0b013e328347473a
Stevenson, 2002, A cognitive remediation programme for adults with attention deficit hyperactivity disorder, Aust. N. Z. J. Psychiatry, 36, 610, 10.1046/j.1440-1614.2002.01052.x
Strasser, 2005, Effects of different nicotine replacement therapies on postcessation psychological responses, Addict. Behav., 30, 9, 10.1016/j.addbeh.2004.04.005
Sweet, 2010, Effects of nicotine withdrawal on verbal working memory and associated brain response, Psychiatry Res., 183, 69, 10.1016/j.pscychresns.2010.04.014
Swick, 2011, Are the neural correlates of stopping and not going identical? Quantitative meta-analysis of two response inhibition tasks, Neuroimage, 56, 1655, 10.1016/j.neuroimage.2011.02.070
Teneggi, 2005, Effect of sustained-release (SR) bupropion on craving and withdrawal in smokers deprived of cigarettes for 72 h, Psychopharmacology (Berl), 183, 1, 10.1007/s00213-005-0145-x
Terry, 2003, The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development, J. Pharmacol. Exp. Ther., 306, 821, 10.1124/jpet.102.041616
Trimmel, 2004, Effects of transdermally administered nicotine on aspects of attention, task load, and mood in women and men, Pharmacol. Biochem. Behav., 78, 639, 10.1016/j.pbb.2004.04.030
Tuesta, 2011, Recent advances in understanding nicotinic receptor signaling mechanisms that regulate drug self-administration behavior, Biochem. Pharmacol., 82, 984, 10.1016/j.bcp.2011.06.026
Turner, 2011, Parallel anxiolytic-like effects and upregulation of neuronal nicotinic acetylcholine receptors following chronic nicotine and varenicline, Nicotine Tob. Res., 13, 41, 10.1093/ntr/ntq206
Vansickel, 2011, Methylphenidate increases cigarette smoking in participants with ADHD, Psychopharmacology (Berl), 218, 381, 10.1007/s00213-011-2328-y
Vansickel, 2007, A pharmacological analysis of stimulant-induced increases in smoking, Psychopharmacology (Berl), 10.1007/s00213-007-0786-z
Weinberger, 2012, The relationship of major depressive disorder and gender to changes in smoking for current and former smokers: longitudinal evaluation in the US population, Addiction, 107, 1847, 10.1111/j.1360-0443.2012.03889.x
Weinberger, 2013, The relationship of dysthymia, minor depression, and gender to changes in smoking for current and former smokers: longitudinal evaluation in the U.S. population, Drug Alcohol Depend., 127, 170, 10.1016/j.drugalcdep.2012.06.028
Wild, 2008, Status of computerized cognitive testing in aging: a systematic review, Alzheimer's Dement.: the journal of the Alzheimer's Association, 4, 428, 10.1016/j.jalz.2008.07.003
Wilens, 2008, Cigarette smoking associated with attention deficit hyperactivity disorder, J. Pediatrics, 153, 414, 10.1016/j.jpeds.2008.04.030
Wilkinson, 2012, Genetic background influences the effects of withdrawal from chronic nicotine on learning and high-affinity nicotinic acetylcholine receptor binding in the dorsal and ventral hippocampus, Psychopharmacology (Berl), 1
Wilkinson, 2011, The effects of galantamine on nicotine withdrawal-induced deficits in contextual fear conditioning in C57BL/6 mice, Behav. Brain Res., 223, 53, 10.1016/j.bbr.2011.04.010
Wonnacott, 1997, Presynaptic nicotinic ACh receptors, Trends Neurosci., 20, 92, 10.1016/S0166-2236(96)10073-4
Wouda, 2011, Varenicline attenuates cue-induced relapse to alcohol, but not nicotine seeking, while reducing inhibitory response control, Psychopharmacology (Berl), 1
Wykes, 2011, A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes, Am. J. Psychiatry, 168, 472, 10.1176/appi.ajp.2010.10060855
Xian, 2003, The heritability of failed smoking cessation and nicotine withdrawal in twins who smoked and attempted to quit, Nicotine Tob. Res., 5, 245, 10.1080/14622200307225
Xu, 2005, Brain activity in cigarette smokers performing a working memory task: effect of smoking abstinence, Biol. Psychiatry, 58, 143, 10.1016/j.biopsych.2005.03.028